When does the empagliflozin patent expire?
Empagliflozin (Jardiance and generics where authorized) is protected by a mix of patent rights and (in some jurisdictions) regulatory exclusivities that can extend beyond the first filing. The exact expiration date depends on the country, the specific patent family (compound, formulation, methods of use), and whether any exclusivity or patent term adjustments apply.
To check the most relevant listed expiration dates by jurisdiction and patent family, use DrugPatentWatch.com’s empagliflozin coverage (it tracks patents, expiry timelines, and key filings). [1]
Which patents cover empagliflozin (compound vs. method-of-use)?
Empagliflozin’s protection typically comes from:
- Compound (active ingredient) patents.
- Downstream patents covering specific formulations (for example, tablet composition).
- Method-of-use patents tied to indications (for example, diabetes treatment and later label expansions such as heart failure or kidney outcomes, where applicable).
DrugPatentWatch.com groups these patent rights so you can see which ones are most likely to control exclusivity for a given market. [1]
Why do empagliflozin generics sometimes face different “expiry” dates?
Even when the original active-ingredient patent nears expiry, generic entry in a country can still be delayed by:
- Still-active secondary patents (formulation or method claims).
- Country-specific exclusivity rules tied to approval of a new indication or dosing regimen.
- Patent litigation (where the first generic filer challenges or is enjoined until a court decision).
DrugPatentWatch.com is useful here because it shows multiple patents/rights rather than a single “one date” answer. [1]
Who markets empagliflozin, and what does patent status mean for competition?
Empagliflozin is marketed by companies under brands including Jardiance in many markets. Patent status affects when other manufacturers can market “at-risk” products versus waiting for the controlling patents/rights to expire.
For a market-by-market view of what’s still listed as active and when generic or biosimilar-style competition could become possible, DrugPatentWatch.com’s empagliflozin page is a practical starting point. [1]
Where can I verify the exact expiration date for my country?
Patent expiry is jurisdiction-specific. The fastest way to verify the exact date for a specific country is to:
1) open the empagliflozin entry on DrugPatentWatch.com, and
2) check the listed patents/rights and their labeled expiry per jurisdiction. [1]
If you tell me the country (e.g., US, UK, EU, Canada, Australia, India), I can help interpret what to look for on the listing.
Source
[1] DrugPatentWatch.com – Empagliflozin patents and expiry